ConductScience.org, home

Trial · NCT00103285

Results by group31

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm I-combination ChemotherapyStandard and Intensified therapy83.8295% Confidence Interval 78.86 to 88.78percent probability
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm II-combination ChemotherapyStandard and Intensified therapy88.8995% Confidence Interval 84.79 to 92.99percent probability
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm III-combination ChemotherapyStandard and Intensified therapy88.3495% Confidence Interval 83.99 to 92.69percent probability
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm IV-combination ChemotherapyStandard and Intensified therapy90.5195% Confidence Interval 86.55 to 94.47percent probability
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm I-combination ChemotherapyStandard therapy87.4195% Confidence Interval 83.63 to 91.19percent probability
Event-free Survival (EFS) for SR-Average ALL PatientsGroup 2-SR-avg ALL, Arm II-combination ChemotherapyStandard therapy88.2995% Confidence Interval 84.76 to 91.82percent probability
Event-free Survival (EFS) for SR-Low PatientsSR-low ALL, Arm I-combination Chemotherapy95.2295% Confidence Interval 93.6 to 96.9Percent probability
Event-free Survival (EFS) for SR-Low PatientsSR-low ALL, Arm II-combination Chemotherapy93.9695% Confidence Interval 92.1 to 95.8Percent probability
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyPhysical Impairment 1 mth after diagnosis76.3995% Confidence Interval 68.6 to 83.1Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyPhysical Impairment 6 mths after diagnosis42.7595% Confidence Interval 34.2 to 51.7Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyPhysical Impairment 12 mths after diagnosis29.4195% Confidence Interval 21.9 to 37.8Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyPhysical Impairment 3 mths post therapy27.8495% Confidence Interval 19.2 to 37.9Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapySocial Impairment 1 mth after diagnosis43.3695% Confidence Interval 35.1 to 51.9Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapySocial Impairment 6 mths after diagnosis23.6695% Confidence Interval 16.7 to 31.9Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapySocial Impairment 12 mths after diagnosis23.5395% Confidence Interval 16.7 to 31.6Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapySocial Impairment 3 mths post-therapy25.7795% Confidence Interval 17.4 to 35.7Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyEmotional Impairment 1 mth after diagnosis38.8995% Confidence Interval 30.9 to 47.4Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyEmotional Impairment 6 mths after diagnosis17.5695% Confidence Interval 11.5 to 25.2Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyEmotional Impairment 12 mths after diagnosis13.9795% Confidence Interval 8.6 to 21.0Percentage of participants
Health-related Quality of Life Relative to Physical, Social and Emotional ImpairmentInduction TherapyEmotional Impairment 3 mths post-therapy8.2595% Confidence Interval 3.6 to 15.6Percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00103285/results